SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-6.51%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$281M
AUM Growth
+$281M
(-14%)
Cap. Flow
-$22.1M
Cap. Flow
% of AUM
-7.85%
Top 10 Holdings %
Top 10 Hldgs %
48.11%
Holding
91
New
17
Increased
9
Reduced
22
Closed
24
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$18.6M |
| 2 |
AGN
Allergan plc
AGN
|
$16.9M |
| 3 |
Pfizer
PFE
|
$10.3M |
| 4 |
McKesson
MCK
|
$8.64M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$8.52M |
Top Sells
| 1 |
GSK
GSK
|
$15.2M |
| 2 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$12.1M |
| 3 |
Medpace
MEDP
|
$11.3M |
| 4 |
Novartis
NVS
|
$8.3M |
| 5 |
Humana
HUM
|
$7.51M |
Sector Composition
| 1 | Healthcare | 90.79% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Novo Nordisk
NVO
$251B
| $4.09M | 1.32% |
+79,100
| New | +$4.09M |
|
|
RVNC
27
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.97M | 1.28% |
305,664
-98,000
| -24% | -$1.27M |
|
28
Integer Holdings
ITGR
$3.78B
| $3.82M | 1.23% |
50,596
-5,248
| -9% | -$397K |
|
29
Molina Healthcare
MOH
$9.8B
| $3.57M | 1.15% |
32,490
+2,490
| +8% | +$273K |
|
30
Cross Country Healthcare
CCRN
$438M
| $3.37M | 1.09% |
327,466
+68,739
| +27% | +$708K |
|
|
HSACU
31
DELISTED
Health Sciences Acquisitions Corporation Units
HSACU
| $3.29M | 1.06% |
307,000
| – | – |
|
|
AMRN
32
Amarin Corp
AMRN
$311M
| $3.14M | 1.01% |
+207,400
| New | +$3.14M |
|
33
Icon
ICLR
$13.8B
| $3.03M | 0.97% |
20,530
-10,000
| -33% | -$1.47M |
|
|
SYNH
34
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $2.84M | 0.91% |
53,297
-72,602
| -58% | -$3.86M |
|
|
FOMX
35
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $2.8M | 0.9% |
920,796
-374,873
| -29% | -$1.14M |
|
|
ARNA
36
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $2.01M | 0.65% |
+43,857
| New | +$2.01M |
|
37
Premier
PINC
$2.14B
| $1.98M | 0.64% |
+68,597
| New | +$1.98M |
|
38
Harrow
HROW
$1.44B
| $1.9M | 0.61% |
338,614
-132,500
| -28% | -$745K |
|
|
UROV
39
DELISTED
Urovant Sciences Ltd.
UROV
| $1.79M | 0.58% |
188,842
-31,200
| -14% | -$295K |
|
40
Exicure
XCUR
$35.4M
| $1.71M | 0.55% |
+674,672
| New | +$1.71M |
|
41
Dynavax Technologies
DVAX
$1.19B
| $1.66M | 0.54% |
+465,299
| New | +$1.66M |
|
|
PFNX
42
DELISTED
Pfenex Inc.
PFNX
| $1.63M | 0.53% |
193,608
-20,000
| -9% | -$169K |
|
43
Actinium Pharmaceuticals
ATNM
$55.5M
| $1.38M | 0.44% |
6,003,142
+1,067,892
| +22% | +$246K |
|
|
LOGC
44
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $1.33M | 0.43% |
122,536
-10,004
| -8% | -$108K |
|
45
Exagen
XGN
$217M
| $1.32M | 0.42% |
+85,000
| New | +$1.32M |
|
46
Gyre Therapeutics
GYRE
$703M
| $1.13M | 0.36% |
229,677
-284,867
| -55% | -$1.4M |
|
47
Bionano Genomics
BNGO
$17.6M
| $1M | 0.32% |
1,439,612
-80,181
| -5% | -$55.8K |
|
48
Achieve Life Sciences
ACHV
$152M
| $892K | 0.29% |
524,413
| – | – |
|
49
MEI Pharma
MEIP
$160M
| $435K | 0.14% |
258,852
-1,251,234
| -83% | -$2.1M |
|
50
Axsome Therapeutics
AXSM
$6.05B
| $411K | 0.13% |
20,310
| – | – |
|